Argan (AGX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Reported $874M in revenues, $6.15 diluted EPS, $114M EBITDA, $525M in cash/investments, and $1.36B project backlog as of January 31, 2025.
Power industry services accounted for 79% of revenues, with significant growth in renewable and gas-fired projects.
Fiscal 2025 saw a 52.5% increase in consolidated revenues and an 80% increase in project backlog year-over-year.
Returned $19.8M to shareholders via dividends and share repurchases; increased quarterly dividend by 25% to $0.375 per share.
Hosted first Investor Day at NYSE and expanded shareholder engagement initiatives.
Voting matters and shareholder proposals
Election of nine directors to serve until the 2026 annual meeting.
Advisory vote on executive compensation (say-on-pay) and on the frequency of such votes (say-on-frequency), with board recommending annual votes.
Approval of an amendment to the Certificate of Incorporation to limit personal liability of certain officers.
Ratification of Grant Thornton LLP as independent registered public accountants for fiscal year ending January 31, 2026.
Board of directors and corporate governance
Board consists of nine nominees, with 78% qualifying as independent.
Board committees: Audit, Compensation, Nominating/Corporate Governance, Responsible Business, and Executive.
Board and committee meetings had 100% attendance in fiscal 2025.
New directors added in 2024 and 2025 to enhance board diversity and expertise.
Board succession planning and director nomination process emphasize diversity, integrity, and relevant experience.
Latest events from Argan
- Revenue up 52%, net income $7.9M, EBITDA $11.9M, and backlog at $824M with strong liquidity.AGX
Q1 20251 Feb 2026 - Q2 revenue up 61% to $227M, net income $18.2M, backlog $1.03B, cash $485M, no debt.AGX
Q2 202522 Jan 2026 - Q3 revenue up 57% to $257M, net income $28M, $800M backlog, dividend up 25%.AGX
Q3 202511 Jan 2026 - Record revenue, EPS, and $1.4B backlog highlight robust growth and industry demand.AGX
Q4 202526 Dec 2025 - Record backlog, rising profits, and strong cash position drive robust growth momentum.AGX
Q3 20265 Dec 2025 - Record growth, robust governance, and enhanced shareholder returns define fiscal 2025.AGX
Proxy Filing1 Dec 2025 - Key votes include director elections, say-on-pay, auditor ratification, and officer liability limits.AGX
Proxy Filing1 Dec 2025 - Record backlog, surging profits, and robust demand drive strong growth and outlook.AGX
Q1 202621 Nov 2025 - Record net income, improved margins, and a $2.0B backlog underscore strong growth momentum.AGX
Q2 202610 Sep 2025